Kaifeng Wei
Nanjing University of Chinese Medicine(CN)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Natural product bioactivities and synthesis, Viral gastroenteritis research and epidemiology, Bone Metabolism and Diseases
Most-Cited Works
- → Correction: Corrigendum: Frankincense and myrrh suppress inflammation via regulation of the metabolic profiling and the MAPK signaling pathway(2015)308 cited
- → Cellular Senescence and Regulated Cell Death of Tubular Epithelial Cells in Diabetic Kidney Disease(2022)95 cited
- → Frankincense and myrrh suppress inflammation via regulation of the metabolic profiling and the MAPK signaling pathway(2015)64 cited
- → Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine booster(2023)38 cited
- → Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA.5/BF.7/XBB Breakthrough Infection and BA.5/BF.7-XBB Reinfection(2024)9 cited
- → Immunogenicity of monkeypox virus surface proteins and cross-reactive antibody responses in vaccinated and infected individuals: implications for vaccine and therapeutic development(2025)8 cited
- → Exploring the mechanism of Carbonized Typhae Pollen in treating blood stasis syndrome through metabolic profiling: the synergistic effect of hemostasis without blood stasis(2025)6 cited
- → Enhanced neutralization of SARS-CoV-2 XBB sub-lineages and BA.2.86 by a tetravalent COVID-19 vaccine booster(2023)5 cited
- → Artemisia keiskeana Miq. alleviates oxidative stress and ferroptosis in APAP-induced liver injury by mediating Nrf2/GPX4/NF-κB signaling pathway through ESR1(2025)4 cited
- → A curcumin-induced assembly of a transferrin nanocarrier system and its antitumor effect(2022)4 cited